Cardiovascular diseases and depression: A meta-analysis and Mendelian randomization analysis
Jun Zeng1, Yuting Qiu1, Chengying Yang2
1Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Cardiovascular disease (CVD) and depression are significantly linked, increasing mortality risk. This study used meta-analysis and Mendelian randomization to confirm this association and suggest depression impacts CVD development.
Area of Science:
- Cardiology
- Psychiatry
- Genetics
Background:
- Depression is a common comorbidity in cardiovascular disease (CVD) patients, negatively impacting health outcomes.
- The exact mechanisms linking CVD and depression are not fully understood.
- Understanding this relationship is crucial for patient management.
Purpose of the Study:
- To investigate the association between CVD and depression using meta-analysis.
- To clarify the causal relationship between CVD and depression via bidirectional Mendelian randomization (MR).
- To assess the impact of depression on mortality in CVD patients.
Main Methods:
- A meta-analysis of 39 studies involving 63,444 CVD patients.
- Bidirectional Mendelian randomization (MR) analysis using the inverse-variance weighted method.
- Subgroup analyses for coronary artery disease and heart failure.
Main Results:
- A significant association was found between CVD and depression/anxiety, with an overall depression prevalence of 20.8% in CVD patients.
- Depression prevalence was 19.8% in coronary artery disease and 24.7% in heart failure patients.
- MR analysis indicated a causal role of depression in the development of certain CVD subtypes, and depressive symptoms increased all-cause mortality risk.
Conclusions:
- There is a significant link between CVD and depression/anxiety, elevating all-cause mortality risk.
- Genetically-informed evidence suggests depression contributes to the development and progression of specific CVD subtypes.
- Addressing depression in CVD patients is vital for improving cardiovascular outcomes.
More Related Videos
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Regression Toward the Mean
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Longitudinal Studies


